• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Opna Bio Receives Orphan Drug Designation For OPN-2853

    BUSINESSWIRE

    Opna Bio Highlights Dual-Action Therapy For Myeloma

    BUSINESSWIRE

    Opna Bio Announces 2025 ASH Presentations on Preclinical Data

    BUSINESSWIRE

    Opna Bio Gets Orphan Drug Status For OPN-6602 In Multiple Myeloma

    BUSINESSWIRE

    Opna Bio Announces Phase 1 Data for OPN-2853 in Myelofibrosis

    BUSINESSWIRE

    Opna Bio to Present Data at ASH on BET Inhibitor in Myelofibrosis

    BUSINESSWIRE

    Opna Bio Doses First Patient In Phase 1 Study Of OPN-6602 For Multiple Myeloma

    BUSINESSWIRE

    Opna Bio Presents Preclinical Data on OPN-6602 and OPN-9840 at AACR

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.